Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l'Autorité des Marchés Financiers (Regulation of the French stock market authority)
Sanofi
a French
société anonyme
with a registered share capital of 2,522,417,258 €
Registered office : 54, rue La Boétie - 75008 Paris - France
Registered at the Paris Commercial and Companies Registry under number 395 030 844
Date |
Total number of issued shares |
Number of real
voting rights (excluding treasury shares) |
Theoretical number of
voting rights (including treasury shares)* |
September 30, 2017 | 1,262,785,247 | 1,398,898,309 | 1,409,441,890 |
* Pursuant to article 223-11 of the Règlement général de l'Autorité des Marchés Financiers.
This information is also available on the internet website of sanofi under « Regulated Information in France »: http://en.sanofi.com/investors/regulated_info_france/regulated_info_france.asp
Investor Relations Department
Europe Tel: + 33 1 53 77 45 45 US Tel: + 1 908 981 5560
e-mail:
IR@sanofi.com
Media Relations Department
Tel: + 33 1 53 77 46 46
e-mail:
MR@sanofi.com
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sanofi via GlobeNewswire
Upcoming Life Sciences Events
- April 2024
- London: LSX World Congress
- May 2024
- Seoul: BIO KOREA 2024
- Biotechgate Digital Partnering May 2024